Alfred K. Cheung

26.1k total citations · 6 hit papers
297 papers, 15.4k citations indexed

About

Alfred K. Cheung is a scholar working on Nephrology, Surgery and Emergency Medical Services. According to data from OpenAlex, Alfred K. Cheung has authored 297 papers receiving a total of 15.4k indexed citations (citations by other indexed papers that have themselves been cited), including 168 papers in Nephrology, 81 papers in Surgery and 78 papers in Emergency Medical Services. Recurrent topics in Alfred K. Cheung's work include Dialysis and Renal Disease Management (129 papers), Central Venous Catheters and Hemodialysis (78 papers) and Blood Pressure and Hypertension Studies (55 papers). Alfred K. Cheung is often cited by papers focused on Dialysis and Renal Disease Management (129 papers), Central Venous Catheters and Hemodialysis (78 papers) and Blood Pressure and Hypertension Studies (55 papers). Alfred K. Cheung collaborates with scholars based in United States, China and Canada. Alfred K. Cheung's co-authors include Tom Greene, Srinivasan Beddhu, Andrew S. Levey, John K. Leypoldt, Michael V. Rocco, Guofen Yan, Mark J. Sarnak, Brendan P. Teehan, Prabir Roy‐Chaudhury and Lee W. Henderson and has published in prestigious journals such as New England Journal of Medicine, Circulation and Annals of Internal Medicine.

In The Last Decade

Alfred K. Cheung

291 papers receiving 15.0k citations

Hit Papers

Effect of Dialysis Dose and Membrane Flux in Maintenance ... 2000 2026 2008 2017 2002 2021 2000 2014 2014 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Effect of Dialysis Dose and Membrane Flux in Maintenance Hemodialysis
    2002 1.3k citations Garabed Eknoyan, Gerald J. Beck et al. profile →
  2. KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease
    2021 657 citations Alfred K. Cheung, William C. Cushman et al. Kidney International profile →
  3. Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients
    2000 632 citations Alfred K. Cheung, Guofen Yan et al. Kidney International profile →
  4. GFR Decline as an End Point for Clinical Trials in CKD: A Scientific Workshop Sponsored by the National Kidney Foundation and the US Food and Drug Administration
    2014 389 citations Andrew S. Levey, Tom Greene et al. American Journal of Kidney Diseases profile →
  5. The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: The Systolic Blood Pressure Intervention Trial (SPRINT)
    2014 360 citations Walter T. Ambrosius, Alfred K. Cheung et al. profile →
  6. Executive summary of the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease
    2021 176 citations Alfred K. Cheung, William C. Cushman et al. Kidney International profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alfred K. Cheung United States 63 8.8k 4.1k 3.6k 3.2k 3.0k 297 15.4k
Allan J. Collins United States 80 13.7k 1.6× 3.7k 0.9× 4.9k 1.3× 2.5k 0.8× 3.8k 1.3× 275 22.6k
Robert N. Foley United States 70 11.9k 1.4× 3.7k 0.9× 5.4k 1.5× 1.9k 0.6× 4.1k 1.4× 199 19.6k
Gerald J. Beck United States 61 8.0k 0.9× 2.9k 0.7× 2.5k 0.7× 2.0k 0.6× 3.3k 1.1× 168 15.4k
J. Michael Lazarus United States 62 10.0k 1.1× 2.9k 0.7× 2.1k 0.6× 2.5k 0.8× 2.6k 0.9× 200 14.9k
Franz Schaefer Germany 60 8.0k 0.9× 2.6k 0.6× 3.3k 0.9× 1.8k 0.6× 2.4k 0.8× 417 17.8k
Bradley A. Warady United States 62 10.0k 1.1× 2.8k 0.7× 1.6k 0.4× 1.7k 0.5× 2.5k 0.8× 519 17.9k
Raymond T. Krediet Netherlands 66 12.1k 1.4× 4.2k 1.0× 1.2k 0.3× 3.2k 1.0× 2.4k 0.8× 341 15.0k
Brad C. Astor United States 70 14.7k 1.7× 4.0k 1.0× 7.4k 2.0× 2.0k 0.6× 5.3k 1.8× 299 28.9k
Raymond M. Hakim United States 63 7.3k 0.8× 2.7k 0.7× 1.2k 0.3× 2.8k 0.9× 2.1k 0.7× 153 12.0k
Roberto Pecoits‐Filho Brazil 52 7.0k 0.8× 2.3k 0.6× 2.3k 0.6× 882 0.3× 1.7k 0.6× 383 13.2k

Countries citing papers authored by Alfred K. Cheung

Since Specialization
Citations

This map shows the geographic impact of Alfred K. Cheung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alfred K. Cheung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alfred K. Cheung more than expected).

Fields of papers citing papers by Alfred K. Cheung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alfred K. Cheung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alfred K. Cheung. The network helps show where Alfred K. Cheung may publish in the future.

Co-authorship network of co-authors of Alfred K. Cheung

This figure shows the co-authorship network connecting the top 25 collaborators of Alfred K. Cheung. A scholar is included among the top collaborators of Alfred K. Cheung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alfred K. Cheung. Alfred K. Cheung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ascher, Simon B., Ronit Katz, Michelle M. Estrella, et al.. (2025). Associations of Urine Biomarkers During Ambulatory Acute Kidney Injury With Subsequent Recovery in Kidney Function: Findings From the SPRINT Study. American Journal of Kidney Diseases. 86(2). 155–165. 1 indexed citations
2.
Ascher, Simon B., Ronit Katz, Stein Hallan, et al.. (2025). Plasma Biomarkers of Kidney Tubule Health during Ambulatory AKI and Kidney Function Recovery in SPRINT. Clinical Journal of the American Society of Nephrology. 21(3). 460–470.
3.
Nee, Robert, et al.. (2024). Role of Age and Competing Risk of Death in the Racial Disparity of Kidney Failure Incidence after Onset of CKD. Journal of the American Society of Nephrology. 35(3). 299–310. 3 indexed citations
4.
Boucher, Robert E., Guo Wei, Jincheng Shen, et al.. (2024). Baseline Diastolic BP and BP-Lowering Effects on Cardiovascular Outcomes and All-Cause Mortality. Journal of the American Society of Nephrology. 36(5). 911–922. 3 indexed citations
5.
Bansal, Shweta, Robert E. Boucher, Jincheng Shen, et al.. (2024). Role of Diuretics in Cardiovascular Events and Mortality in Systolic Blood Pressure Intervention Trial. Clinical Journal of the American Society of Nephrology. 19(5). 620–627.
6.
Agarwal, Adhish, Srinivasan Beddhu, Robert E. Boucher, et al.. (2024). Evaluation of renal sodium handling in heart failure with preserved ejection fraction: A pilot study. Physiological Reports. 12(9). e16033–e16033. 3 indexed citations
7.
Sohn, Michael B., Bei Gao, Cynthia Kendrick, et al.. (2023). Targeting Gut Microbiome With Prebiotic in Patients With CKD: The TarGut-CKD Study. Kidney International Reports. 9(3). 671–685. 11 indexed citations
8.
Burrows, Nilka Rı́os, Alain K. Koyama, Devasmita Choudhury, et al.. (2022). Age-Related Association between Multimorbidity and Mortality in US Veterans with Incident Chronic Kidney Disease. American Journal of Nephrology. 53(8-9). 652–662. 6 indexed citations
9.
Wright, Jackson T., Paul K. Whelton, Karen Johnson, et al.. (2021). SPRINT Revisited: Updated Results and Implications. Hypertension. 78(6). 1701–1710. 16 indexed citations
10.
Ilkun, Olesya, Tom Greene, Alfred K. Cheung, et al.. (2020). The Influence of Baseline Diastolic Blood Pressure on the Effects of Intensive Blood Pressure Lowering on Cardiovascular Outcomes and All-Cause Mortality in Type 2 Diabetes. Diabetes Care. 43(8). 1878–1884. 16 indexed citations
11.
He, Yong, et al.. (2020). Analyses of hemodialysis arteriovenous fistula geometric configuration and its associations with maturation and reintervention. Journal of Vascular Surgery. 73(5). 1778–1786.e1. 13 indexed citations
12.
13.
14.
Chonchol, Michel, et al.. (2015). Association of BP with Death, Cardiovascular Events, and Progression to Chronic Dialysis in Patients with Advanced Kidney Disease. Clinical Journal of the American Society of Nephrology. 10(6). 934–940. 23 indexed citations
15.
Terry, Christi M., Huan Li, Donald Blumenthal, et al.. (2012). In vivo evaluation of the delivery and efficacy of a sirolimus-laden polymer gel for inhibition of hyperplasia in a porcine model of arteriovenous hemodialysis graft stenosis. Journal of Controlled Release. 160(3). 459–467. 30 indexed citations
16.
Chelamcharla, Madhukar, John K. Leypoldt, & Alfred K. Cheung. (2005). Dialyzer membranes as determinants of the adequacy of dialysis. Seminars in Nephrology. 25(2). 81–89. 23 indexed citations
17.
Goldfarb‐Rumyantzev, Alexander S., et al.. (2005). A crossover study of short daily haemodialysis. Nephrology Dialysis Transplantation. 21(1). 166–175. 40 indexed citations
18.
Cheung, Alfred K., Michael V. Rocco, Guofen Yan, et al.. (2005). Serum β-2 Microglobulin Levels Predict Mortality in Dialysis Patients. Journal of the American Society of Nephrology. 17(2). 546–555. 312 indexed citations
19.
Cheung, Alfred K., et al.. (2002). Optimal Use of Hemodialyzers. Contributions to nephrology. 129–137. 6 indexed citations
20.
Cheung, Alfred K., et al.. (1999). Ultrafiltration method for measuring vascular access flow rates during hemodialysis. Kidney International. 56(3). 1129–1135. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Allan J. Collins Breakdown of academic impact, for papers by Robert N. Foley Breakdown of academic impact, for papers by Gerald J. Beck Breakdown of academic impact, for papers by J. Michael Lazarus Breakdown of academic impact, for papers by Franz Schaefer Breakdown of academic impact, for papers by Bradley A. Warady Breakdown of academic impact, for papers by Raymond T. Krediet Breakdown of academic impact, for papers by Brad C. Astor Breakdown of academic impact, for papers by Raymond M. Hakim Breakdown of academic impact, for papers by Roberto Pecoits‐Filho
Rankless by CCL
2026